Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression in nematodes, mice and human cells

ABSTRACT: MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression in nematodes, mice and human cells

PROVIDER: PRJNA690776 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13387400_1.fastq.gz	Fastqsanger.gz
	SRR13387400_2.fastq.gz	Fastqsanger.gz
	SRR13387401_1.fastq.gz	Fastqsanger.gz
	SRR13387401_2.fastq.gz	Fastqsanger.gz
	SRR13387402_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 43

Similar Datasets

MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression in nematodes, mice and human cells

Project description:CRISPR-mediated gene activation (CRISPRa) is a promising therapeutic gene editing strategy without inducing DNA double-strand breaks (DSBs). However, in vivo implementation of these CRISPRa systems remains a challenge. Here, we report a compact and robust miniCas9 activator (termed miniCAFE) for in vivo activation of endogenous target genes. The system relies on recruitment of an engineered minimal nuclease-null Cas9 from Campylobacter jejuni and potent transcriptional activators to a target locus by a single guide RNA. It enables robust gene activation in human cells even with a single DNA copy and is able to promote lifespan of C. elegans through activation of longevity-regulating genes. As proof-of-concept, delivered within an all-in-one adeno-associated virus (AAV), miniCAFE can activate Fgf21 expression in the liver and regulate energy metabolism in adult mice. Thus, miniCAFE holds great therapeutic potential against human diseases.

2021-04-21 | GSE164452 | GEO

Compact engineered human mechanosensitive transactivation modules enable potent and versatile synthetic transcriptional control

Project description:Engineered transactivation domains (TADs) combined with programmable DNA binding platforms have revolutionized synthetic transcriptional control. Despite recent progress in programmable CRISPR/Cas-based transactivation (CRISPRa) technologies, the TADs used in these systems often contain poorly tolerated elements and/or are prohibitively large for many applications. Here we defined and optimized minimal TADs built from human mechanosensitive transcription factors (MTFs). We used these components to construct potent and compact multipartite transactivation modules (MSN, NMS, and eN3×9) and to build the CRISPR-dCas9 recruited enhanced activation module (CRISPR-DREAM) platform. We found that CRISPR-DREAM was specific, robust across mammalian cell types, and efficiently stimulated transcription from diverse regulatory loci. We also showed that MSN and NMS were portable across Type I, II, and V CRISPR systems, TALEs, and ZF proteins. Further, as proofs of concepts, we used dCas9-NMS to efficiently reprogram human fibroblasts into iPSCs and demonstrated that MTF TADs are efficacious and well tolerated in therapeutically important primary human cell types. Finally, we leveraged the compact and potent features of these engineered TADs to build new dual and all-in-one CRISPRa AAV systems. Altogether, these compact human TADs, fusion modules, and new delivery architectures should be valuable for synthetic transcriptional control in biomedical applications.

2023-07-31 | GSE238178 | GEO

MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression in vivo.

Project description:CRISPR-mediated gene activation (CRISPRa) is a promising therapeutic gene editing strategy without inducing DNA double-strand breaks (DSBs). However, in vivo implementation of these CRISPRa systems remains a challenge. Here, we report a compact and robust miniCas9 activator (termed miniCAFE) for in vivo activation of endogenous target genes. The system relies on recruitment of an engineered minimal nuclease-null Cas9 from Campylobacter jejuni and potent transcriptional activators to a target locus by a single guide RNA. It enables robust gene activation in human cells even with a single DNA copy and is able to promote lifespan of Caenorhabditis elegans through activation of longevity-regulating genes. As proof-of-concept, delivered within an all-in-one adeno-associated virus (AAV), miniCAFE can activate Fgf21 expression in the liver and regulate energy metabolism in adult mice. Thus, miniCAFE holds great therapeutic potential against human diseases.

| S-EPMC8053112 | biostudies-literature

Compact engineered human mechanosensitive transactivation modules enable potent and versatile synthetic transcriptional control

Project description:Compact engineered human mechanosensitive transactivation modules enable potent and versatile synthetic transcriptional control

| PRJNA998265 | ENA

Multiplexed activation of endogenous genes by CRISPRa elicits potent anti-tumor immunity

Project description:Multiplexed activation of endogenous genes by CRISPRa elicits potent anti-tumor immunity

| PRJNA553242 | ENA

Nematodes

Project description:Nematodes Metagenome

| PRJNA836018 | ENA

Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors

Project description:Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors

| PRJNA1057933 | ENA

Soil nematodes

Project description:Soil nematodes